Sign in
4

Changes in Ownership

Axsome Therapeutics, Inc. Filed Acc 0000950170-25-027070

Options or other derivatives

  • Chief Financial Officer acquired 28,362 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Pizzie Nick Chief Financial Officer 2025-02-21 Grant or award · Employee Stock Option (Right to Buy) +9,516 9,516 D: show line 1 in the form
Pizzie Nick Chief Financial Officer 2025-02-21 Grant or award · Restricted Stock Units +9,423 9,423 D: show line 2 in the form
Pizzie Nick Chief Financial Officer 2025-02-24 Grant or award · Performance Stock Units +9,423 9,423 D: show line 3 in the form
Loading xslF345X05/ownership.xml…